Skip to content
Search

Latest Stories

India reports lowest daily rise in new Covid-19 infections in 46 days

India reports lowest daily rise in new Covid-19 infections in 46 days

INDIA recorded a single-day rise of 1,65,553 new Covid-19 cases, the lowest in 46 days, taking the country's infection tally to 2,78,94,800, according to union health ministry data on Sunday (30).

The daily positivity declined to 8.02 per cent, remaining below the 10 per cent mark for the sixth consecutive day, while the weekly positivity rate dropped to 9.36 per cent, it said.


The death toll due to the disease climbed to 3,25,972 in the country with 3,460 fatalities being recorded in a span of 24 hours.

Also, 20,63,839 Covid-19 tests were conducted in the country on Saturday (29), taking the total to 34,31,83,748, the ministry said.

Meanwhile, the number of active cases has reduced to 21,14,508, comprising 7.58 per cent of the total infections, with the national Covid-19 recovery rate has improved to 91.25 per cent. The number of people who have recuperated from the disease has surged to 2,54,54,320, while the case fatality rate stands at 1.17 per cent, the data stated.

A total of 3,25,972 Covid-19 deaths have been reported so far in the country, including 94,030 from Maharashtra, 28,298 from Karnataka, 24,073 from Delhi, 23,261 from Tamil Nadu, 20,208 from Uttar Pradesh, 15,268 from West Bengal, 14,305 from Punjab and 12,979 from Chhattisgarh.

The government on Sunday (30) said that India will have nearly 120 million doses of COVID-19 vaccines available for domestic use in June.

This marks a significant jump from the 79.4 million doses that were available in May.

India has administered about 212 million doses, the most after China and the United States, but has given the necessary two doses to only about three per cent of its 1.35 billion people.

India on Sunday reported its lowest daily rise in new coronavirus infections in 46 days at 165,553 cases during the previous 24 hours, while deaths rose by 3,460.

Earlier this month, a top government adviser said more than 2 billion doses of coronavirus vaccines will likely be available in India between August to December this year, including those from the two domestic manufacturers.

More For You

The Sattva Collective launches to support South Asian women

The initiative will empower more women to speak openly about their health

iStock

The Sattva Collective launches to support South Asian women through midlife and menopause

A new community-led initiative has been launched in the UK to provide culturally sensitive support for South Asian women navigating midlife and menopause.

The Sattva Collective, founded by certified Midlife and Menopause Coach Kiran Singh, officially launched on 14 May 2025 as a registered Community Interest Company (CIC). It is the first initiative in the UK focused specifically on the experiences of South Asian women during what Singh describes as a “deeply personal and often stigmatised” phase of life.

Keep ReadingShow less
Bella Hadid

Bella Hadid stuns at the Cannes Film Festival 2025 in a daring Saint Laurent black gown

Instagram/ Vogue France

Bella Hadid pushes Cannes 2025 dress code to the edge in a daring Saint Laurent black gown

Bella Hadid’s return to the Cannes Film Festival was anything but quiet. This year, the model showed up ready to challenge the red carpet rules without actually breaking them.

With new restrictions in place like no sheer fabrics, no visible nudity, no dramatic trains or bulky silhouettes, fashion-watchers wondered if Bella, known for her daring Cannes looks in the past, would tone it down. Instead, she found a clever way around the rules.

Keep ReadingShow less
Gen Z

These terms provide insight into how Gen Z views the world around them

iStock

11 Gen Z slang terms that have already peaked in 2025

Language is constantly evolving, and nowhere is this more apparent than in the lexicon of Gen Z. As the first generation to grow up fully immersed in social media, their language is influenced by memes, viral videos, and digital culture. With 2025 underway, several Gen Z slang terms have already become ubiquitous, appearing in everyday conversations, on social media platforms, and even in mainstream media. Here are 11 slang terms that have already peaked this year.

1. Delulu

"Delulu," short for "delusional," is one of the most prominent slang terms of 2025. It’s used to describe someone who holds unrealistic beliefs or makes outlandish claims. The term was catapulted into the spotlight after Australian Prime Minister Anthony Albanese used it in Parliament to describe his political opponents, referring to them as being "delulu with no solulu," which translates to "delusional with no solution." The term has since been widely adopted by young people, particularly in online communities. It’s now frequently used to poke fun at someone’s exaggerated or disconnected views on social media.

Keep ReadingShow less
FDA Urges Immediate Stop to Use of Recalled Eye Care Products

The FDA has categorised the recall as a Class II

iStock

Eye care products recalled across US over sterility concerns, FDA warns users to stop immediately

A nationwide recall of five eye care products has been issued in the United States after concerns were raised about their sterility and manufacturing standards. BRS Analytical Services, LLC, the manufacturer of the affected products, has urged consumers to stop using them immediately due to potential safety risks.

The recall, shared in a press release by healthcare distributor AvKARE, affects more than 1.8 million cartons of eye drops. The US Food and Drug Administration (FDA) identified multiple violations during a recent audit, including failures to meet Current Good Manufacturing Practice (CGMP) standards.

Keep ReadingShow less
Zepbound Surpasses Wegovy in Groundbreaking Weight Loss Study

This may influence future decisions on treatment options for obesity patients

iStock

Eli Lilly's Zepbound outshines Wegovy in weight loss trial results

Eli Lilly announced on Sunday that its weight-loss drug, Zepbound, outperformed Novo Nordisk's Wegovy in a head-to-head trial, showing superior results across five weight-loss targets, including waist circumference reduction.

This trial, the first of its kind comparing the two widely used obesity medications, offers Eli Lilly a competitive advantage as it aims to secure broader insurance coverage in the rapidly growing obesity drug market, which is projected to exceed $150 billion annually by the next decade.

Keep ReadingShow less